KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

CURAM FORTE 625 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

625 MG

 

GENERIC NAME:

COAMOXICLAV

 

MANUFACTURER:

BIOCHEMIE GESELLSCHAFT

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

B

 

INDICATIONS:

Infection, ear, middle

Infection, lower respiratory tract

Infection, sinus

Infection, skin and skin structure

Infection, upper respiratory tract

Infection, urinary tract

 

SIDE EFFECTS:

vasculitis

abdominal pain

acute generalized exanthematous pustulosis (AGEP)

agitation

agranulocytosis

anaphylactic shock

anemia

angioedema

anorexia

anxiety

arthralgia

bullous rash

candidiasis

cholestasis

confusion

crystalluria

diarrhea

dizziness

dyspepsia

elevated hepatic enzymes

enterocolitis

eosinophilia

erythema multiforme

exfoliative dermatitis

fever

gastritis

glossitis

headache

hematuria

hemolysis

hemolytic anemia

hepatitis

insomnia

interstitial nephritis

jaundice

leukopenia

maculopapular rash

myalgia

nausea/vomiting

nephrotic syndrome

neutropenia

oliguria

platelet dysfunction

prolonged bleeding time

pruritus

pseudomembranous colitis

purpura

seizures

serum sickness

Stevens-Johnson syndrome

stomatitis

superinfection

thrombocytopenia

tongue discoloration

tooth discoloration

toxic epidermal necrolysis

urticaria

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

asthma

breast-feeding

carbapenem hypersensitivity

cephalosporin hypersensitivity

cholestasis

colitis

diabetes mellitus

dialysis

diarrhea

eczema

GI disease

hepatic disease

infants

infection

jaundice

leukemia

mononucleosis

neonates

phenylketonuria

pregnancy

renal failure

renal impairment

 

ADULT DOSE:

Antibacterial- Pneumonia and other severe infections- Oral, 875 mg of amoxicillin and 125 mg of clavulanic acid every twelve hours or 500 mg of amoxicillin and 125 mg of clavulanic acid every eight hours. Other infections- Oral, 500 mg of amoxicillin and 125 mg of clavulanic acid every twelve hours or 250 mg of amoxicillin and 125 mg of clavulanic acid every eight hours. [Chancroid] - Oral, 500 mg of amoxicillin and 125 mg of clavulanic acid, or 500 mg of amoxicillin and 250 mg of clavulanic acid every eight hours for three to seven days.

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Antibacterial- Infants and children up to 40 kg of body weight - See Amoxicillin and Clavulanate Potassium for Oral Suspension . Note: Because the 250-mg tablet and the 250-mg chewable tablet have different amoxicillin-to-clavulanic acid ratios, the 250-mg tablet should not be used in children who weigh less than 40 kg. Children 40 kg of body weight and over- See Usual adult and adolescent dose. 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT